Neurology Clinical Trials Market Size, Share & Trends Report

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68038-352-2
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Market Segmentation

  • Neurology Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Neurology ClinicalTrials Study Design Outlook (Revenue, USD Million, 2016 - 2028)
    • Interventional
    • Observational
    • Expanded Access
  • Neurology Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)
    • Epilepsy
    • Parkinson's Disease (PD)
    • Huntington's Disease
    • Stroke
    • Traumatic Brain Injury (TBI)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Muscle regeneration
    • Others
  • Neurology Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
      • North America Neurology Clinical Trials Market, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • North America Neurology Clinical Trials Market, By Study Design
        • Interventional
        • Observational
        • Expanded Access
      • North America Neurology Clinical Trials Market, By Indication
        • Epilepsy
        • Parkinson's Disease (PD)
        • Huntington's Disease
        • Stroke
        • Traumatic Brain Injury (TBI)
        • Amyotrophic Lateral Sclerosis (ALS)
        • Muscle regeneration
        • Others
      • U.S.
        • U.S. Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • U.S. Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • U.S. Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Canada
        • Canada Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Canada Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Canada Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
    • Europe
      • Europe Neurology Clinical Trials Market, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Europe Neurology Clinical Trials Market, By Study Design
        • Interventional
        • Observational
        • Expanded Access
      • Europe Neurology Clinical Trials Market, By Indication
        • Epilepsy
        • Parkinson's Disease (PD)
        • Huntington's Disease
        • Stroke
        • Traumatic Brain Injury (TBI)
        • Amyotrophic Lateral Sclerosis (ALS)
        • Muscle regeneration
        • Others
      • U.K.
        • U.K. Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • U.K. Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • U.K. Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Germany
        • Germany Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Germany Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Germany Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • France
        • France Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • France Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • France Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Italy
        • Italy Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Italy Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Italy Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Spain
        • Spain Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Spain Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Spain Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
    • Asia Pacific
      • Asia Pacific Neurology Clinical Trials Market, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Asia Pacific Neurology Clinical Trials Market, By Study Design
        • Interventional
        • Observational
        • Expanded Access
      • Asia Pacific Neurology Clinical Trials Market, By Indication
        • Epilepsy
        • Parkinson's Disease (PD)
        • Huntington's Disease
        • Stroke
        • Traumatic Brain Injury (TBI)
        • Amyotrophic Lateral Sclerosis (ALS)
        • Muscle regeneration
        • Others
      • India
        • India Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • India Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • India Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Japan
        • Japan Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Japan Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Japan Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • China
        • China Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • China Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • China Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Australia
        • Australia Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Australia Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Australia Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • South Korea
        • South Korea Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • South Korea Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • South Korea Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
    • Latin America
      • Latin America Neurology Clinical Trials Market, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Latin America Neurology Clinical Trials Market, By Study Design
        • Interventional
        • Observational
        • Expanded Access
      • Latin America Neurology Clinical Trials Market, By Indication
        • Epilepsy
        • Parkinson's Disease (PD)
        • Huntington's Disease
        • Stroke
        • Traumatic Brain Injury (TBI)
        • Amyotrophic Lateral Sclerosis (ALS)
        • Muscle regeneration
        • Others
      • Brazil
        • Brazil Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Brazil Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Brazil Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Mexico
        • Mexico Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Mexico Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Mexico Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Argentina
        • Argentina Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
          • Argentina
        • Argentina Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Argentina Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • Colombia
        • Colombia Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Colombia Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • Colombia Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
    • MEA
      • MEA Neurology Clinical Trials Market, By Phase
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • MEA Neurology Clinical Trials Market, By Study Design
        • Interventional
        • Observational
        • Expanded Access
      • MEA Neurology Clinical Trials Market, By Indication
        • Epilepsy
        • Parkinson's Disease (PD)
        • Huntington's Disease
        • Stroke
        • Traumatic Brain Injury (TBI)
        • Amyotrophic Lateral Sclerosis (ALS)
        • Muscle regeneration
        • Others
      • South Africa
        • South Africa Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • South Africa Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • South Africa Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • South Arabia
        • South Arabia Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • South Arabia Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • South Arabia Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others
      • UAE
        • UAE Neurology Clinical Trials Market, By Phase
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • UAE Neurology Clinical Trials Market, By Study Design
          • Interventional
          • Observational
          • Expanded Access
        • UAE Neurology Clinical Trials Market, By Indication
          • Epilepsy
          • Parkinson's Disease (PD)
          • Huntington's Disease
          • Stroke
          • Traumatic Brain Injury (TBI)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Muscle regeneration
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon